Revna Biosciences
PrivateLast Round
Growth Equity
Mar 1, 2026
Total Funding Raised
$118,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Revna Biosciences is a biotechnology company that provides precision medicine services, advanced molecular diagnostics, and biobanking infrastructure in Africa.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revna Biosciences Comparables
Compare Revna Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yemaachi Biotechnology | 84% | |
| Roche Holding | 63% | |
| Nalagenetics | 57% | |
Revna Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Mar 1, 2026 | ||||
| VC Round | Dec 1, 2024 | ||||
| Grant | Mar 27, 2024 | ||||
| Grant | Aug 24, 2023 | ||||
| Seed | Nov 11, 2022 |
Revna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aruwa Capital Management | VC Round |
| Jaza Rift Ventures | Seed |
| African Diaspora Network | Seed, Grant |
| develoPPP Ventures | Grant |
| Mirepa Capital | Growth Equity |
| develoPPP | Grant |
| Tekedia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 23% QoQ, from 26 to 32 employees.
- Mar 2, 2026
Monthly visitors increased 439% MoM, reaching 248.
Revna Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revna Biosciences's valuation, stock price, and market status.